Ninepoint Partners Proposes Major Overhauls to Two Funds

  • Ninepoint Partners LP proposes changing investment objectives for two funds: Ninepoint Cannabis & Alternative Health Fund and Ninepoint Risk Advantaged U.S. Equity Index Fund.
  • Unitholder approval is required, with special meetings scheduled for June 29, 2026, and potential implementation by July 6, 2026.
  • Ninepoint Cannabis & Alternative Health Fund would shift to a covered call strategy, reducing management fees and changing its risk rating from High to Medium.
  • Ninepoint Risk Advantaged U.S. Equity Index Fund would focus on writing put options and call options for income and capital appreciation.
  • Faircourt Asset Management Inc. will no longer serve as the sub-adviser for the Ninepoint Cannabis & Alternative Health Fund.

Ninepoint Partners' proposed changes reflect a strategic pivot towards income-generating strategies amid evolving market conditions. The shift away from cannabis-focused investments and the emphasis on covered call and options-writing strategies highlight a broader industry trend towards risk-adjusted returns. With approximately $8 billion in assets under management, the success of these changes could influence the firm's competitive positioning in the alternative investment space.

Investor Approval
Whether unitholders will approve the proposed changes, given the significant shifts in strategy and structure.
Execution Risk
How smoothly Ninepoint Partners can implement these changes and whether the new strategies will meet investor expectations.
Market Impact
The potential impact of these changes on Ninepoint Partners' overall asset management business and investor confidence.